Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
06/2002
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/04/2002US6399809 From malonic acid monoester amide
06/04/2002US6399798 Method of preparing alkylated salicylamides
05/2002
05/30/2002WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002WO2002042248A2 Naphthalene derivatives
05/30/2002WO2002014264A3 (hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production
05/30/2002WO2001021160B1 Carboxymide and aniline derivatives as selective inhibitors of pathogens
05/30/2002US20020065316 Citrullimycines, a process for their production and their use as pharmaceuticals
05/30/2002CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/29/2002EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/23/2002WO2002040446A1 Glucagon antagonist/inverse agonist
05/23/2002WO2002040445A1 Glucagon antagonists/inverse agonists
05/23/2002WO2002040444A1 Glucagon antagonists/inverse agonists
05/23/2002WO2002039967A1 Novel coupler for use in oxidative hair dyeing
05/23/2002WO2001098235A3 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
05/23/2002US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
05/23/2002CA2424723A1 Novel coupler for use in oxidative hair dyeing
05/22/2002EP0966434B1 Aminophenol derivatives and their use in cosmetics
05/22/2002EP0681575B1 Process for the preparation of Baccatin III analogs bearing new C2 and C4 functional groups
05/22/2002CN1350565A Nucleators for crystallizable thermoplastic polymers
05/22/2002CN1350452A Preventive or therapeutic drugs for diabetes
05/21/2002US6392001 Process for the production of light-stable polyisocyanates containing allophanate groups
05/21/2002US6391917 Analgesic
05/21/2002CA2230750C Antiherpes peptidomimetic compounds
05/16/2002WO2002038534A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
05/16/2002US20020058784 Generation of preferential compound; obtain sample of diamino acid such as 2,3 diaminopropionic acid, incubate with compound with free amino group, recover urein
05/16/2002US20020058654 For therapy of uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, breast cancer and ovarian cancer; depletion of oocytes; spermatocyte depletion; for female and male contraception
05/16/2002CA2428266A1 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
05/15/2002EP1204408A2 An improved form of form i celiprolol hydrochloride
05/15/2002CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders
05/15/2002CN1349519A Glucokinase activators
05/14/2002US6388153 Chain transfer agents
05/14/2002US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors
05/14/2002US6387949 Substituted urea compounds useful in pain management
05/10/2002WO2002036553A2 Substituted alkanoic acids
05/08/2002EP1203765A2 Process for the synthesis of urea
05/08/2002CN1348443A N-substituted-N'-substituted urea derivative and medicinal compositions containing the same
05/07/2002US6384220 Antidiabetic agents increasing the expression of glucokinase (gk) to improve glucose tolerance; increase in glucose exposure coupled through gk in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition
05/07/2002US6384174 Polyurethanes
05/07/2002US6384075 Treating diseases in which mast cell dysfunction is involved
05/02/2002WO2001081298A3 Cyclic carboxylic acids as integrin antagonists
05/02/2002US20020052417 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
05/02/2002US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder
05/02/2002US20020052348 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
05/02/2002US20020052028 Bio-intermediates for use in the chemical synthesis of polyketides
05/02/2002EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides
05/02/2002EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor
05/01/2002CN1347404A (-)-Verbenzone derivs.
05/01/2002CN1347318A Inhibitors of IMPDH enzyme
05/01/2002CN1083831C Novel tricyclic compounds and drug compositions contg. same
04/2002
04/30/2002US6380392 Complexes
04/25/2002US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/24/2002EP1198456A2 Potassium channel openers
04/23/2002US6376546 Biphenyl-5-alkanoic acid derivatives and use thereof
04/23/2002US6376538 Antiinflammatory agents; autoimmune diseases
04/18/2002WO2002030915A2 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport
04/18/2002WO2002030876A2 Cyclic carboxylic acids as integrin antagonists
04/18/2002WO2002030875A1 Beta-amino acid derivatives as integrin receptor antagonists
04/18/2002WO2002030874A2 Aliphatic, cyclic amino carboxylic acids as integrin antagonists
04/18/2002WO2002003995A3 Treatment of male sexual dysfunction
04/18/2002US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
04/18/2002US20020045749 Antibacterial agents
04/18/2002CA2424951A1 Beta-amino acid derivatives as integrin receptor antagonists
04/17/2002CN1344711A Combined prep. of ammonia and urea
04/16/2002US6372933 Reacting benzoxazolinone with nucleophilic aniline derivative in presence of lewis acid to open oxazolinone ring to form phenyl urea compound
04/11/2002WO2002028824A1 Citrullimycines, a process for their production and their use as pharmaceuticals
04/11/2002WO2002028820A1 Nitroso diphenylamine derivatives
04/11/2002WO2001045678A3 Medicament, a method for its production and the use thereof
04/11/2002US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
04/11/2002US20020042512 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators
04/11/2002CA2424684A1 Nitroso diphenylamine derivatives
04/11/2002CA2424273A1 Citrullimycines, a process for their production and their use as pharmaceuticals
04/10/2002CN1344259A Processes and intermediates for prepn. of 1,3-diazin-b 6-ones and uracils
04/10/2002CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
04/09/2002US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
04/04/2002WO2002026701A2 Ionic liquids and their use as solvents
04/04/2002WO2002004407A3 7-substituted tetracycline compounds
04/04/2002WO2001094301A3 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
04/04/2002DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use
04/03/2002EP1193249A1 Citrullimycines, a process for their production and their use as pharmaceuticals
04/03/2002EP1047719B1 Mixtures containing diisocyanates with allophanate groups derived from alicyclic alcohols
03/2002
03/28/2002WO2002024635A2 Aminoalcohol derivatives
03/28/2002WO2002024613A2 Resorcinol derivatives
03/28/2002US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes
03/28/2002US20020037905 N-phenyl-N'-(2-carboxyphenyl) urea, for example; chloride channel blockers; such as for treating bone metabolic disorders
03/28/2002US20020037854 Use of at least one no synthase inhibitor for treating sensitive skin
03/28/2002CA2423262A1 Resorcinol derivatives
03/27/2002EP1190710A1 Preventive or therapeutic drugs for diabetes
03/27/2002EP1189612A1 Vla-4 inhibitor compounds
03/27/2002EP0832079B1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
03/26/2002US6362360 Sensitizers for insulin resistance and associated conditions dyslipidemia and hyperglycemia
03/26/2002US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use
03/21/2002WO2002022844A1 Optically active fluorophenylalanine derivative and process for producing the same
03/21/2002WO2002022627A2 Ligands for metabotropic glutamate receptors
03/21/2002WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists
03/21/2002WO2001055081A3 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use
03/21/2002US20020035293 Process for the integrated preparation of ammonia and urea
03/21/2002US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors
03/21/2002US20020035114 Substituted dimeric compounds
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 99